MentionFox
Home › Who owns › Apnimed, Inc.
Owners, funding and legal record

Who owns Apnimed, Inc.? Owners, funding and legal record

Before you sign with, sell to or invest in Apnimed, Inc.

MentionFox check on Apnimed, Inc.: no red flags found in 12 sources (checked 6 November 2026). mentionfox.com/c/who-owns/apnimed-inc

Check Apnimed, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Apnimed, Inc.?

Apnimed, Inc. is a publicly traded company (Nasdaq: APMD). The most recent 5%+ ownership report names Shionogi & Co. Ltd. holding 7.1% (Schedule 13G, filed 2026-11-04).

As of November 6, 2026, Apnimed, Inc. is a publicly traded company (Nasdaq: APMD); its largest reported holder is Ameriprise, with 18.9% on Schedule 13G of August 7, 2026, then Shionogi & Co. Ltd. (7.1%). The largest insider holding is Morningside Venture Investments Ltd, a 10% owner, with 14,068,550 shares (33.8% of shares outstanding), per Form 4 of August 5, 2026 (Schedule 13G, August 7, 2026).

Ameriprise Financial, Inc. also filed stake reports on 65 other companies ↓

Is this your company?

About to sign with, pay or invest in Apnimed, Inc.? See the free Snapshot first.

Watch Apnimed, Inc.

Free to see. No signup.

Is Apnimed, Inc. a real, registered company?

Before you sign or pay

Who are Apnimed, Inc.'s owners and officers?

Apnimed, Inc.: incorporated in Delaware; business address in Cambridge, Massachusetts; industry Pharmaceutical Preparations (Schedule 13G, 2026-11-04).

Officers and directors, each with the role and the filing that names them:

ReportHolderShare
Schedule 13G, 2026-11-04Shionogi & Co LTD7.1%
Schedule 13G, 2026-08-07Ameriprise Financial, Inc.18.9%
Schedule 13G, 2026-08-06Tao Capital Management LP5.2%

Questions about who owns Apnimed, Inc.

Who owns Apnimed, Inc.?

On this page, 3 holders' latest ownership filings report 5% or more of Apnimed, Inc.: Ameriprise Financial, Inc. (18.9%, Schedule 13G, filed 2026-08-07), Shionogi & Co LTD (7.1%, Schedule 13G, filed 2026-11-04) and Tao Capital Management LP (5.2%, Schedule 13G, filed 2026-08-06).

Who are the largest shareholders of Apnimed, Inc.?

By the share each holder's latest filing reports, the largest holders of Apnimed, Inc. on this page are Ameriprise Financial, Inc. (18.9%), Shionogi & Co LTD (7.1%) and Tao Capital Management LP (5.2%).

When did Ameriprise Financial, Inc. buy into Apnimed, Inc.?

The filings give report dates, not purchase dates. The earliest filing from Ameriprise Financial, Inc. on this page is the Schedule 13G, filed 2026-08-07, reporting 18.9%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Apnimed, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Apnimed, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Apnimed, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    14 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Which insiders own Apnimed, Inc. shares?

Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.

Shares outstanding: 41,630,779 as of 2026-09-04, from the company's latest SEC cover page.

How much has Apnimed, Inc. raised?

FiledSoldOffered
Form D, 2026-03-27$25M$25M
Form D, 2025-09-24$23M$23M
Form D, 2025-04-24$16.50M$16.50M
Form D, 2023-11-08$0$37.50M
Form D, 2022-12-23$79.75M$79.75M

Latest IPO step: Apnimed, Inc. filed its final IPO prospectus, ticker APMD (424B4, 2026-07-31).

IPO filings: 424B4, 2026-07-31, S-1/A, 2026-07-27, S-1, 2026-07-10; ticker APMD on Nasdaq Global Select Market.

Keep reading

More on Apnimed, Inc. and the records around it.

Apnimed, Inc. elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/apnimed-inc
Last updated 2026-11-06
Who owns Apnimed? Nasdaq: APMD; Ameriprise 18.9%. MentionFox, 2026-11-06. https://mentionfox.com/who-owns/apnimed-inc